|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
Phase I Clinical Trial of
the Farnesyltransferase Inhibitor BMS-214662 Given as a 1-Hour
Intravenous Infusion in Patients With Advanced Solid Tumors Clin Cancer Res. 2004 Apr 1;10(7):2222-30. PMID: 15073096
|
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |